FDA Commissioner Hahn’s Priorities Include Workplace Development Issues, Data Collection

 
• By Sue Darcey
  
Stephen Hahn of MD Anderson Cancer Center is expected to be nominated for FDA commissioner

More from Regulation

More from Policy & Regulation